Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B

Liver

Volumn 18, Issue 5, 1998, Pages 360-365

  Fattovich, Giovanna ^a   Ribero, Maria Lisa ^b   Favarato, Susanna ^c   Azzario, Franco ^d   Donato, Francesco ^e   Giustina, Giuliano ^c   Fasola, Michele ^b   Pantalena, Maurizio ^a   Portera, Giuseppe ^b   Tagger, Alessandro ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antibody to HGV; Chronic hepatitis; Clinical course; Coinfection; GB virus C; Hepatitis B virus; Hepatitis C virus; Hepatitis delta virus; Hepatitis G virus

Indexed keywords

HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE;

EID: 7844252262     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00818.x     Document Type: Article

References (23)

1. SIMONS J N, LEARY T P, DAWSON G J, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-9.
2. LEARY T P, MUERHOFF A S, SIMONS J N, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-7.
3. LINNEN J, WAGES JR J, ZHANG-KECK Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
4. TACKE M, KIYOSAWA K, STARK K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-20.
5. ALTER M J, CALLAGHER M, MORRIS T T, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-6.
6. ALTER H J, NAKATSUJI Y, MELPOLDER J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54.
7. AIKAWA T, SUGAI Y, OKAMOTO H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-6.
8. HERINGLAKE S, TILLMANN H L, CORDES-TEMME P, et al. GBV-C/HGV is not the major cause of autoimmune hepatitis. J Hepatol 1996; 25: 980-4.
9. BERG T, DIRLA U, NAUMANN U, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996; 25: 763-8.
10. GOESER T, SEIPP S, WAHL R, et al. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J Hepatol 1997; 26: 498-502.
11. MARTINOT M, MARCELLIN P, BOYER N, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-a in patients with chronic hepatitis C. Ann Intern Med 1997; 126: 874-881.
12. KAO J H, CHEN P J, LAI M Y, et al. GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis. chronic liver disease, and liver cancer. Gastroenterology 1997; 112: 1265-70.
13. MARRONE A, SHIH J W K, NAKATSUJI Y, et al. Serum hepatitis G virus RNA in patients with chronic viral hepatitis. Am J Gastroenterol 1997; 92: 1992-6.
14. WANG K S, CHOO Q L, WEINER A J, et al. Structure, sequence and expression of the hepatitis delta (δ) viral genome. Nature 1986; 323: 508-51.
15. RUMI M G, SANTAGOSTINO E, MORFINI M, et al. A multicenter controlled, randomized, open trial of interferon alpha 2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Blood 1997; 89: 3529-33.
16. FATTOVICH G, RUGGE M, BROLLO L, et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6: 167-172.
17. BIANCHI L, DE GROOTE J, DESMET V J, et al. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914-9.
18. STARK K, BIENZLE U, HESS G, et al. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-3.
19. DILLE B J, SUROWY T K, GUTIERREZ R A, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997; 175: 458-461.
20. PRATI D, CAPELLI C, ZANELLA A, et al. Asymptomatic hepatitis G virus infection in blood donors. Transfusion 1997; 37: 1200-4.
21. TACKE M, SCHMOLKE S, SCHLUETER V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26: 1626-33.
22. SEMPRINI A E, PERSICO T, THIERS V, et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 1998; 177: 848-854.
23. ZANETTI A R, TANZI E, ROMANÒ L, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. J Med Virol 1998; 54: 107-112.